Eurofins Diatherix is an innovative laboratory providing accurate and actionable results in one day for infectious diseases utilizing molecular technologies, including proprietary TEM-PCR™.

Eurofins Diatherix Distinctions:

  • Delivers one-day results
  • Identifies bacteria regardless of recent antibiotic use
  • Offers simplicity of single-sample collection
  • Identifies difficult to culture pathogens
  • Yields a higher level of analytical sensitivity and specificity

Eurofins Diatherix Benefits:

TEM-PCR technology is a proprietary, multiplex amplification platform designed to overcome the challenges that exist with conventional laboratory methods and real-time PCR applications.

Peter Carothers
President


Randy Ward, MT (ASCP)
Chief Operations Officer


Stanley Lu
Chief Information Officer


Traci Tyree
Chief Financial Officer


Jess Wisotskey
Vice President of Operations, Clinical Laboratory Director


Bernard Klemchak
Vice President of Laboratory Services


Louis Leong
Vice President of R&D


Scott Clemmons
Vice President of Systems Development

All resident associate companies on the HudsonAlpha campus are independently owned and operated.